Patient | Age | Sex | Disease status | Karyotype | ELN genetic group | FLT3-ITD | NPM1 |
---|---|---|---|---|---|---|---|
0276 | 29 | F | ID | Aberrant | Adverse | wt | wt |
2562 | 52 | M | ID | Intermediate aberrant | n.a. | wt | wt |
3140 | 74 | M | ID | Normal | Intermediate | wt | wt |
3073 | 54 | M | R | Normal | Favourable | wt | wt |
1233 | 49 | F | ID | Complex aberrant | Adverse | mut | mut |
3826 | 85 | M | ID | Aberrant | Adverse | wt | wt |
2449 | 30 | F | ID | Aberrant | Favourable | wt | wt |
4169 | 20 | M | ID | Aberrant | Intermediate | wt | wt |
0178 | 56 | F | ID | Complex aberrant | Favourable | wt | wt |
3386 | 52 | M | ID | Normal | Favourable | wt | mut |
3776 | 35 | F | ID | Normal | Favourable | wt | wt |
3221 | 59 | M | ID | Normal | Favourable | wt | mut |
3495 | 58 | M | ID | Normal | Favourable | mut | wt |
0885 | 74 | F | ID | Normal | Intermediate | mut | mut |
4321 | 50 | F | ID | Normal | Intermediate | mut | mut |
6789 | 68 | M | ID | Normal | Favourable | mut | wt |
0252 | 84 | F | ID | Aberrant | Favourable | mut | mut |
1421 | 66 | F | ID | Aberrant/normal | Adverse | wt | wt |
0682 | 56 | F | ID | Complex aberrant | Adverse | wt | wt |
7782 | 76 | M | ID | Complex aberrant | Adverse | wt | wt |
5964 | 87 | F | ID | Complex aberrant | Adverse | wt | wt |
AML-491 [3] | 53 | F | R | del(7)(q21) | Adverse | wt | wt |
AML-579 [3] | 51 | M | R | Normal | Adverse | mut, LOH | mut |
AML-640 | 79 | M | R | t(11;15) | Intermediate | mut | mut |
AML-979 | 56 | F | R | Normal | n.a. | wt + mut subclone | mut |